Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,681 | -5,959 | -3,857 | -3,489 | -2,842 |
| Depreciation Amortization | 576 | 790 | 838 | 987 | 1,179 |
| Accounts receivable | -127 | 25 | -54 | -66 | 76 |
| Other Working Capital | -356 | 387 | 69 | 58 | -691 |
| Other Operating Activity | 66 | 1,529 | -53 | 63 | -140 |
| Operating Cash Flow | $-3,522 | $-3,228 | $-3,056 | $-2,448 | $-2,419 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 935 | -15,404 | 0 | N/A | N/A |
| PPE Investments | -133 | -19 | -7 | -55 | -138 |
| Other Investing Activity | -18 | -18 | -6 | -40 | -20 |
| Investing Cash Flow | $784 | $-15,441 | $-13 | $-96 | $-158 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 214 | 21,982 | 3,307 | 3,114 | 3,201 |
| Dividend Paid | -11 | -11 | -11 | -11 | -11 |
| Other Financing Activity | 82 | 1,479 | 0 | 0 | -180 |
| Financing Cash Flow | $285 | $23,450 | $3,296 | $3,104 | $3,010 |
| Beginning Cash Position | 7,680 | 2,900 | 2,673 | 2,112 | 1,679 |
| End Cash Position | 5,227 | 7,680 | 2,900 | 2,673 | 2,112 |
| Net Cash Flow | $-2,453 | $4,780 | $227 | $561 | $433 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,522 | -3,228 | -3,056 | -2,448 | -2,419 |
| Capital Expenditure | -133 | -19 | -7 | -55 | -138 |
| Free Cash Flow | -3,655 | -3,247 | -3,063 | -2,503 | -2,556 |